Alputon Inc. houses our eI2C technology platform in a 10,000 square feet state of the art facility. In addition, there are 10,000 square feet labs for medicinal chemistry, organic synthesis and process chemistry.

A 160,000 square feet R&D building is expected to be operational in early 2008. It will house additional services including bioassay, ADMET, in vitro and in vivo biology, preclinical research and clinical research.

[click to enlarge]